Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Prostate Cancer Care: Integrating Risks, Benefits and Patient Experiences in the New Era of Molecular Imaging

NCT06523777 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06523777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06523777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Prostate Cancer Care: Integrating Risks, Benefits and Patient Experiences in the New Era of Molecular Imaging
Lead sponsor
Yale University
Phase
Observational
Overall status
Active, not recruiting
Start date
July 25, 2024
Completion date
July 25, 2028
Enrollment
350 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer